Short Interest in Moolec Science SA (NASDAQ:MLEC) Declines By 70.1%

Moolec Science SA (NASDAQ:MLECGet Free Report) was the recipient of a large decrease in short interest in the month of March. As of March 13th, there was short interest totaling 17,317 shares, a decrease of 70.1% from the February 26th total of 57,914 shares. Based on an average daily trading volume, of 103,911 shares, the short-interest ratio is currently 0.2 days. Currently, 3.0% of the company’s stock are short sold. Currently, 3.0% of the company’s stock are short sold. Based on an average daily trading volume, of 103,911 shares, the short-interest ratio is currently 0.2 days.

Hedge Funds Weigh In On Moolec Science

An institutional investor recently bought a new position in Moolec Science stock. Citadel Advisors LLC bought a new position in shares of Moolec Science SA (NASDAQ:MLECFree Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned approximately 0.90% of Moolec Science as of its most recent filing with the SEC. Institutional investors and hedge funds own 0.07% of the company’s stock.

Moolec Science Stock Down 3.0%

Moolec Science stock traded down $0.20 during trading on Wednesday, reaching $6.57. The stock had a trading volume of 6,772 shares, compared to its average volume of 1,464,811. Moolec Science has a 52-week low of $3.08 and a 52-week high of $157.05. The stock has a market cap of $4.80 million, a PE ratio of -0.20 and a beta of -0.65. The business has a 50 day moving average price of $8.78 and a 200 day moving average price of $9.33.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded Moolec Science to a “sell” rating in a report on Saturday, February 28th.

Get Our Latest Stock Report on Moolec Science

Moolec Science Company Profile

(Get Free Report)

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

See Also

Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.